Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway.
about
Asymmetric dimethyl-arginine metabolism in a murine model of cigarette smoke-mediated lung inflammationHuman alanine-glyoxylate aminotransferase 2 lowers asymmetric dimethylarginine and protects from inhibition of nitric oxide productionAsymmetric dimethylarginine as a mediator of vascular dysfunction in cirrhosisAsymmetric dimethyarginine as marker and mediator in ischemic strokeAsymmetric dimethylarginine and reactive oxygen species: unwelcome twin visitors to the cardiovascular and kidney disease tablesAsymmetric Dimethylarginine and Its Relation As a Biomarker in Nephrologic DiseasesInteractions among vascular-tone modulators contribute to high altitude pulmonary edema and augmented vasoreactivity in highlandersTranssulfuration pathway thiols and methylated arginines: the Hunter Community StudyPacked red blood cells are an abundant and proximate potential source of nitric oxide synthase inhibitionFarnesoid X receptor agonist reduces serum asymmetric dimethylarginine levels through hepatic dimethylarginine dimethylaminohydrolase-1 gene regulationIncreased protein arginine methylation in chronic hypoxia: role of protein arginine methyltransferasesA functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with insulin sensitivityThe human gene SLC25A29, of solute carrier family 25, encodes a mitochondrial transporter of basic amino acids.Clinical methods for the evaluation of endothelial function-- a focus on resistance arteries.From arginine methylation to ADMA: a novel mechanism with therapeutic potential in chronic lung diseasesHaemodialysis acutely reduces the plasma levels of ADMA without reversing impaired NO-dependent vasodilation.Estradiol stimulates vasodilatory and metabolic pathways in cultured human endothelial cells.Increased asymmetric dimethylarginine in severe falciparum malaria: association with impaired nitric oxide bioavailability and fatal outcomePlatelet aggregation responses are critically regulated in vivo by endogenous nitric oxide but not by endothelial nitric oxide synthaseAsymmetrical dimethylarginine in renal disease: limits of variation or variation limits? A systematic reviewTetrahydrobiopterin in cardiovascular health and disease.Arginine/Asymmetric Dimethylarginine Ratio in Colorectal Surgery.Dimethylarginine dimethylaminohydrolase II overexpression attenuates LPS-mediated lung leak in acute lung injury.Ascorbic acid or L-arginine improves cutaneous microvascular function in chronic kidney disease.Hypothermia decreases cerebrospinal fluid asymmetric dimethylarginine levels in children with traumatic brain injury.Angiotensin II and NADPH oxidase increase ADMA in vascular smooth muscle cellsAsymmetric dimethylarginine potentiates lung inflammation in a mouse model of allergic asthma.Dimethylarginine metabolism during acute and chronic rejection of rat renal allograftsWhy do young people with chronic kidney disease die early?Identification of small-molecule enhancers of arginine methylation catalyzed by coactivator-associated arginine methyltransferase 1.Hypertension Treatment for Patients with Advanced Chronic Kidney Disease.Glutamine supplementation alleviates vasculopathy and corrects metabolic profile in an in vivo model of endothelial cell dysfunctionProtecting against vascular disease in brainSerum asymmetric dimethylarginine, nitrate, vitamin B(12), and homocysteine levels in individuals with pulmonary embolismActivity-based protein profiling of protein arginine methyltransferase 1.Known regulators of nitric oxide synthase and arginase are agonists at the human G-protein-coupled receptor GPRC6A.Redox Control of Protein Arginine Methyltransferase 1 (PRMT1) Activity.Oxidative stress and nitric oxide signaling related biomarkers in patients with pulmonary hypertension: a case control study.The ratio of arginine to dimethylarginines is reduced and predicts outcomes in patients with severe sepsis.Nitric oxide-mediated coronary flow regulation in patients with coronary artery disease: recent advances.
P2860
Q23912498-5E460AD1-7097-492C-B6F3-FDB7E23F4F34Q24292756-0F9BCA27-9848-4FB8-B94D-B7EAB0F2C3F4Q26795604-4FAA41FA-CBA5-43C6-ACED-49A3F876BD89Q26864318-B5BE535F-84D4-4F12-B771-509A5025B024Q26865426-F5042AFE-0AA6-4405-BB9A-6E2DE3A59053Q28078222-89038F59-1E53-4458-A1D0-9C480BE7D6F4Q28483668-16A6C5D9-C338-4AB9-8EC3-0E8E1851CBFFQ28485286-9012ECB2-9A0F-487B-B092-10E82A9CACE6Q28544807-DC12C231-6B39-4AD0-BA05-A489652B7B5BQ28581627-BB01FF1D-8987-4AB6-8B2F-BC14D18FE773Q28594903-0F245E93-D807-4B76-941C-1BBA6AD15F43Q28730293-81D451D3-D9A9-463E-B863-F98AFD177A90Q32884559-18674B89-9AFB-4ED9-A33C-AF66DAAD9260Q33242082-98F2B954-0201-4154-BA2E-B182660FB816Q33403876-4B17C13B-4FDC-4BAE-9B28-73AA12BBE8CCQ33414818-00740379-9A09-4B48-866F-0742802A176DQ33518553-1F818240-2186-4104-9674-D400B0B725CFQ33565412-48A017DA-851D-40E1-95EF-1329639F8708Q33569525-757BE1E9-FFA8-43F9-96FF-E155F4597E74Q33646665-21101CA8-433C-45EF-8D92-EC935BA0C870Q33687812-2487BB98-B532-4D3C-BD86-69DF963B94A9Q33763284-597DC145-F163-4F67-85A6-C0313245DA36Q33799650-4A6E8B78-7C36-4D69-87E4-3D6E276407AFQ34008329-E6FE91C4-DC1D-4DF9-9ED2-0C86552D034EQ34053465-8CE72C9E-8777-49C2-BB53-F228D8C8D953Q34236324-E365FCB5-089B-4DAE-9C80-614DDA1CE3E7Q34426054-7B9E59DB-9CAC-4C50-A284-C96A314CC531Q34426973-987415A1-3583-4FA7-BCAD-C4509E6860D3Q34453230-1B1B9D42-8D2F-4A9C-958B-82907DB62BC7Q34456824-90DB0736-20F5-4E94-9AB3-E7FEDF0FC346Q34763214-C494DEDA-51EB-4C64-BEBD-F340E6924BBDQ34775724-F7FA4C3D-1708-44C5-90A0-47AC19069FE5Q34979773-F01F58AF-3FF9-4455-AB45-9875196D03C7Q35098847-654F0C78-70DA-44D3-AB0E-F944F191FEB9Q35420805-A1F5D0F0-78C2-49B8-A075-499093D62235Q35566536-ED489C54-DE13-4F9D-8616-4BD5D9DB2AA3Q35721676-B646832C-2735-4D0F-87C7-44035CCE77F6Q35770189-2639DCD2-D7BE-47ED-A6FC-77470604B46AQ35797087-A1520DD5-9A74-407C-9F6A-B95DBBBE6693Q35902581-766936E1-A341-4CBF-A023-0DF571E83E7E
P2860
Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Cardiovascular biology of the ...... imethylaminohydrolase pathway.
@ast
Cardiovascular biology of the ...... imethylaminohydrolase pathway.
@en
type
label
Cardiovascular biology of the ...... imethylaminohydrolase pathway.
@ast
Cardiovascular biology of the ...... imethylaminohydrolase pathway.
@en
prefLabel
Cardiovascular biology of the ...... imethylaminohydrolase pathway.
@ast
Cardiovascular biology of the ...... imethylaminohydrolase pathway.
@en
P1476
Cardiovascular biology of the ...... imethylaminohydrolase pathway.
@en
P2093
James Leiper
Patrick Vallance
P304
P356
10.1161/01.ATV.0000128897.54893.26
P407
P577
2004-04-22T00:00:00Z